Plans for Clinical Trials Post Brexit

Plans for clinical trials in the event of a no-deal Brexit have been published by both the Health Research Authority and the Medicines and Healthcare products Regulatory Authority. 

This advice includes: changes to sponsors/legal representatives, IMP certification and importation, amendments to the Research Ethics Committee, and transferring research data between countries.